ghk cu peptide research safety GHK-CU 50mg GHK-Cu Dosage and Protocol: A

Cagrilintide monotherapy produces about 11.8% reduction at 2.4 mg weekly

.GHK-Cu Evidence A small clinical study in people with hair loss found that a topical product containing GHKCu could increase hair follicle size and density, with results in the same general range as lowstrength minoxidil, and with fewer scalp side effects reported by users [10]

Early data suggests it does

Phase 3 monotherapy results A post-hoc analysis of the phase 3 data showed cagrilintide 2.4 mg monotherapy produced 11.8% average body weight reduction versus 2.3% for placebo over 68 weeks

Thats about 4.3 weeks of daily loading, or 1015 weeks at maintenance frequency

Storage: Lyophilized: freeze at 20 C (4 F)